Essentials in Buprenorphine Prescriptions - Live Webinar on June 10, 2025 8PM EST
Learn to address the unmet needs of patients with substance use disorders. This course explores buprenorphine prescribing post X-waiver, providing essential knowledge for healthcare professionals to confidently contribute to opioid use disorder (OUD) treatment. Bridging gaps in understanding, it combines didactic instruction and case-based discussions to empower practitioners in expanding care access.
About this webinar
Patients with substance use disorders (SUD) represent an underserved demographic, often lacking access to qualified healthcare providers for their specialized needs. The recent removal of the X-waiver for buprenorphine prescribing in opioid use disorder (OUD) opens new avenues for medical practitioners to contribute to solving this crisis. Despite this regulatory easing, reluctance persists among providers largely due to gaps in knowledge surrounding buprenorphine’s pharmacology, prescribing guidelines, and management.
This course aims to bridge that knowledge gap by covering the fundamentals of buprenorphine prescribing and its outcomes. Using a blend of didactic instruction and case-based discussions, the course empowers healthcare professionals to confidently integrate buprenorphine into their practice, thereby expanding treatment access for this vulnerable patient population.
At the conclusion of this continuing education activity, the participant will be able to:
Identify the current gaps in care for the treatment of patients with opioid use disorder (OUD)
Describe current treatment recommendations, including non-pharmacologic options, when treating patients with opioid use disorder, with a focus on buprenorphine prescribing
Discuss pertinent monitoring and legal responsibilities for the use of buprenorphine therapy for patients with OUD
Instructors
Bennett Doughty earned his PhD degree from the University of Connecticut School of Pharmacy in 2016. Following graduation, Doughty completed two years of residency training at the VA Connecticut Healthcare System in West Haven, Conn., specializing in psychiatric pharmacy. He joined the Binghamton School of Pharmacy and Pharmaceutical Sciences in 2018 as a clinical assistant professor in psychiatry/neurology within the Department of Pharmacy Practice. He currently is the treasurer/secretary of the New York State chapter of the American College of Clinical Pharmacy (ACCP) and serves on the College of Psychiatric and Neurologic Pharmacists (CPNP) National Consumer Relations Board. His research interests primarily focus on the engagement of patients in substance use disorder treatment, particularly within the opioid epidemic.